Roblin, David, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, and Praveen Anand. “Topical TrkA Kinase Inhibitor CT327 Is an Effective, Novel Therapy for the Treatment of Pruritus Due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients With Psoriasis”. Acta Dermato-Venereologica 95, no. 5 (February 26, 2015): 542–548. Accessed February 25, 2025. https://medicaljournalssweden.se/actadv/article/view/5778.